home / stock / scph / scph quote
Last: | $4.50 |
---|---|
Change Percent: | -0.65% |
Open: | $4.64 |
Close: | $4.50 |
High: | $4.75 |
Low: | $4.49 |
Volume: | 92,041 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.5 | $4.64 | $4.5 | $4.75 | $4.49 | 92,041 | 04-24-2024 |
$4.61 | $4.63 | $4.61 | $4.79 | $4.57 | 85,258 | 04-23-2024 |
$4.57 | $4.58 | $4.57 | $4.66 | $4.45 | 113,931 | 04-22-2024 |
$4.56 | $4.5 | $4.56 | $4.62 | $4.41 | 166,627 | 04-19-2024 |
$4.51 | $4.42 | $4.51 | $4.52 | $4.25 | 223,905 | 04-18-2024 |
$4.42 | $4.69 | $4.42 | $4.755 | $4.41 | 249,573 | 04-17-2024 |
$4.67 | $4.86 | $4.67 | $4.9 | $4.67 | 126,229 | 04-16-2024 |
$4.86 | $4.89 | $4.86 | $4.97 | $4.75 | 184,123 | 04-15-2024 |
$4.93 | $5.09 | $4.93 | $5.13 | $4.93 | 137,212 | 04-12-2024 |
$5.1 | $4.78 | $5.1 | $5.11 | $4.78 | 146,186 | 04-11-2024 |
$4.78 | $4.88 | $4.78 | $4.9 | $4.7 | 248,847 | 04-10-2024 |
$5.02 | $4.94 | $5.02 | $5.12 | $4.8311 | 160,279 | 04-09-2024 |
$4.93 | $5.02 | $4.93 | $5.08 | $4.89 | 138,789 | 04-08-2024 |
$5.03 | $5.18 | $5.03 | $5.18 | $4.98 | 202,699 | 04-05-2024 |
$5.14 | $5.22 | $5.14 | $5.33 | $5.07 | 163,569 | 04-04-2024 |
$5.21 | $4.76 | $5.21 | $5.31 | $4.71 | 258,758 | 04-03-2024 |
$4.78 | $4.78 | $4.78 | $4.86 | $4.65 | 178,690 | 04-02-2024 |
$4.85 | $4.97 | $4.85 | $4.97 | $4.77 | 216,635 | 04-01-2024 |
$5.02 | $5.13 | $5.02 | $5.155 | $4.97 | 110,060 | 03-29-2024 |
$5.02 | $5.13 | $5.02 | $5.155 | $4.97 | 110,060 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end 2024, if successful BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- scPharma...
Generated 4Q 2023 net FUROSCIX ® revenue of $6.1 million, at the upper end of the range provided in January and representing sequential growth of 61% from $3.8 million in 3Q 2023 Generated full-year net FUROSCIX ® revenue of $13.6 million, at the upper end of the range...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...